Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases

L Zeng, K Yang, Y Wu, G Yu, Y Yan, M Hao… - Journal of …, 2024 - Elsevier
BLyS and APRIL have the capability to bind to B cells within the body, allowing these cells to
evade elimination when they should naturally be removed. While BLyS primarily plays a role …

Antibodies in autoimmune neuropathies: what to test, how to test, why to test

E Pascual-Goñi, M Caballero-Ávila, L Querol - Neurology, 2024 - neurology.org
Autoimmune neuropathies are a heterogeneous group of immune-mediated disorders of the
peripheral nerves. Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating …

The autoimmune vulnerability of the node of Ranvier

L Querol, E Delmont, C Lleixà - Journal of the Peripheral …, 2023 - Wiley Online Library
Abstract The nodes of Ranvier (NoR) are essential domains for nerve conduction and their
disruption plays a key role in the pathophysiology of immune‐mediated neuropathies. Our …

Long‐Term Follow Up in Anti‐Contactin‐1 Autoimmune Nodopathy

M Caballero‐Ávila, L Martín‐Aguilar… - Annals of …, 2024 - Wiley Online Library
Objective To analyze long‐term clinical and biomarker features of anti‐contactin‐1 (CNTN1)
autoimmune nodopathy (AN). Methods Patients with anti‐CNTN1+ autoimmune nodopathy …

Serial electrodiagnostic testing: Utility and indications in adult neurological disorders

SL Hearn, AM Stino, IM Howard, G Malhotra… - Muscle & …, 2024 - Wiley Online Library
Although existing guidelines address electrodiagnostic (EDX) testing in identifying
neuromuscular conditions, guidance regarding the uses and limitations of serial (or repeat) …

Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome

G Breville, E Sukockiene, MI Vargas… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Guillain–Barré syndrome (GBS) is an immune-mediated poly
(radiculo) neuropathy with a variable clinical outcome. Identifying patients who are at risk of …

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody

Y Bai, W Li, C Yan, Y Hou, Q Wang - Frontiers in Immunology, 2023 - frontiersin.org
Background Recent studies have reported that similar to other IgG4 autoimmune diseases,
such as muscle-specific kinase antibody-associated myasthenia gravis, most anti …

[HTML][HTML] Novel 3D bioprinting approach for spinal cord injury repair using neural stem cells and TGF-β1 monoclonal antibody

M Deng, G Hu, F Liang, Q Liao, W Ding, B He… - Nano Materials …, 2024 - Elsevier
Objective To investigate the repair of spinal cord injury (SCI) in rats using 3D bioprinted
decellularized extracellular matrix (dECM) hydrogel, neural stem cells (NSCs), and TGF-β1 …

Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies

Y Ren, S Chen, H Yang - Frontiers in Immunology, 2023 - frontiersin.org
This report presents a case of a neurofascin-155 (NF155)+ autoimmune nodopathy (AN)
patient who exhibited resistance to conventional treatments but responded positively to …

Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review

J Chen, L Liu, H Zhu, J Han, R Li, X Gong… - Frontiers in …, 2024 - frontiersin.org
Background Autoimmune nodopathy (AN) has emerged as a novel diagnostic category that
is pathologically different from classic chronic inflammatory demyelinating polyneuropathy …